Subscribe To
PRTK / Paratek Pharmaceuticals to Present at the 5th Annual Evercore ISI HealthCONx Conference
PRTK News
By GlobeNewsWire
March 8, 2023
Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on March 16
BOSTON, March 08, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company will host a conference call a more_horizontal
By GlobeNewsWire
November 21, 2022
Paratek Pharmaceuticals to Present at the 5th Annual Evercore ISI HealthCONx Conference
BOSTON, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the de more_horizontal
By Seeking Alpha
August 3, 2022
Paratek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q2 2022 Results - Earnings Call Transcript
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK ) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Sarah Higgins - VP, Contr more_horizontal
By Seeking Alpha
May 4, 2022
Paratek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q1 2022 Results - Earnings Call Transcript
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK ) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Evan Loh - CEO Sarah Higgins more_horizontal
By Seeking Alpha
March 14, 2022
Paratek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q4 2021 Results - Earnings Call Transcript
Paratek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q4 2021 Results - Earnings Call Transcript more_horizontal